The 2026 IOTOX Symposium: Delivering What Matters – Patient-Centered through IOTOX Translational Science, organized by The University of Texas MD Anderson Cancer Center, is a hybrid educational event scheduled from Friday, April 24, to Saturday, April 25, 2026.

This symposium is dedicated to bridging the gap between translational science and clinical practice, offering healthcare professionals expert insights into the latest research and practical management strategies for immunotherapy toxicities to enhance patient-centered care and outcomes.

Register.